Coverage for tags: Human_cancer_cell_line

Glycosylation sites

XYZ0% 20% 40% 60% 80% 100% Normalised branch obsv.
XYZ0% 20% 40% 60% 80% 100% Normalised branch obsv.
XYZ0% 20% 40% 60% 80% 100% Normalised branch obsv.
01230% 20% 40% 60% Total structs.

Coverage for tags: Human_cancer_cell_line 62 structures

→ 4 → 6 → 4β1 → 3 → 6β1 → 2 → 4α1 → 4β1 → 6β1α2 → 4β1β1 → 2α1 → 4β1 → 6β1α2α1Z49Y46X13442244
YZ0% 20% 40% 60% 80% 100% Normalised branch obsv.
YZ0% 20% 40% 60% 80% 100% Normalised branch obsv.
0120% 20% 40% 60% Total structs.

Coverage for tags: Human_cancer_cell_line 96 structures

→ 3 → 6 → 6 → 2 → 3 → 3β1α1α2 → 4β1 → 3β1α2 → 3 → 4β1α1 → 3β1α2α2Z49Y74366
  1. NeuAc(α2→3) and Fuc(α1→2) on Gal with A antigen
  2. NeuAc(α2→6) on Gal with B antigen
  3. NeuAc(α2→8) on Gal
  4. Type I chain (Gal(β1→3)GlcNAc(β1→3) disaccharide)
  5. Type II chain (Gal(β1→4)GlcNAc(β1→3) disaccharide)
  6. GlcNAc(β1→6) branching
  7. Fuc(α1→4) GlcNAc
  8. Fuc(α1→3) GlcNAc
  9. Fuc(α1→6) on N-linked core GlcNAc

The vividness of a residue is indicative of the number of times it has been observed.

Sdα epitope is GalNAc(β1→4)[NeuAc(α2→3)]Gal

→ 3 → 6 → 3 → 6β1 → 3 → 4β1 → 3 → 6β1α1α2α1 → 3 → 4β1α1 → 3 → 8β1 → 4β1 → 2 → 3 → 3β1α1α2α1α2α1BAiddffgdbheefcea
GlcNAc
GalNAc
Gal
Glc
Man
100%
50%
0%
100%
50%
0%
% of structures residue seen in
→ 3 → 4α2 → 3 → 4β1α2 → 3β1α2100%50%1%
→ 3 → 4α1 → 3 → 4β1α1 → 3β1α1100%50%1%